spironolactone has been researched along with fluorobenzenes in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abellán Guillén, A; Cordeiro, MN; Garrido Escudero, A; Morales Helguera, A; Pérez-Garrido, A | 1 |
| Aznar, S; Brandwein, C; Chourbaji, S; Gass, P; Halldin, C; Kirkegaard, L; Knudsen, GM; Krey, G; Marcussen, AB; Ridder, S; Thomsen, MS; Trajkovska, V | 1 |
| Rossignol, P; Zannad, F | 1 |
4 other study(ies) available for spironolactone and fluorobenzenes
| Article | Year |
|---|---|
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
Topics: beta-Cyclodextrins; Hydrophobic and Hydrophilic Interactions; Organic Chemicals; Quantitative Structure-Activity Relationship | 2009 |
Avoid the risks of mixed medications. How to minimize dangerous interactions with cardiovascular drugs.
Topics: Anticholesteremic Agents; Azetidines; Cardiovascular Agents; Drug Interactions; Eplerenone; Ezetimibe; Fluorobenzenes; Humans; Polypharmacy; Pyrimidines; Rosuvastatin Calcium; Spironolactone; Sulfonamides | 2003 |
Activation of glucocorticoid receptors increases 5-HT2A receptor levels.
Topics: Analysis of Variance; Animals; Autoradiography; Corticosterone; Fluorobenzenes; Gene Expression Regulation; Hippocampus; Hormone Antagonists; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mifepristone; Mineralocorticoid Receptor Antagonists; Piperidines; Protein Binding; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Glucocorticoid; Serotonin Plasma Membrane Transport Proteins; Spironolactone; Tissue Culture Techniques; Tritium | 2009 |
Regional differences in heart failure with preserved ejection fraction trials: when nephrology meets cardiology but east does not meet west.
Topics: Benzimidazoles; Biphenyl Compounds; Female; Fluorobenzenes; Geography; Heart Failure; Humans; Internationality; Irbesartan; Male; Mineralocorticoid Receptor Antagonists; Patients; Pyrimidines; Rosuvastatin Calcium; Spironolactone; Stroke Volume; Sulfonamides; Tetrazoles | 2015 |